Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baofukang suppository for simple vulvovaginal candidiasis
ChiCTR1800015821Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- May 2018
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of baofukang shuan in vulvovaginal candidiasis (VVC) (2 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoints: Improvement of symptoms and signs and Improvement of vaginal microecology. Planned start May 2018; status: not yet recruiting.
02
Drugs
baofukang shuan
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on ChiCTR1800015821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015821.